BONI, CAROLINA
 Distribuzione geografica
Continente #
NA - Nord America 948
EU - Europa 915
AS - Asia 659
AF - Africa 23
SA - Sud America 13
OC - Oceania 1
Totale 2.559
Nazione #
US - Stati Uniti d'America 929
CN - Cina 301
IT - Italia 290
SG - Singapore 264
IE - Irlanda 235
SE - Svezia 164
TR - Turchia 71
DE - Germania 69
FI - Finlandia 46
FR - Francia 40
CA - Canada 18
CI - Costa d'Avorio 18
BR - Brasile 13
BE - Belgio 11
DK - Danimarca 8
NL - Olanda 8
UA - Ucraina 7
AT - Austria 5
GB - Regno Unito 5
JP - Giappone 5
LT - Lituania 5
RO - Romania 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
IN - India 4
ES - Italia 3
KR - Corea 3
TH - Thailandia 3
BD - Bangladesh 2
HK - Hong Kong 2
PK - Pakistan 2
TW - Taiwan 2
TZ - Tanzania 2
ZA - Sudafrica 2
AL - Albania 1
AU - Australia 1
EE - Estonia 1
ET - Etiopia 1
LU - Lussemburgo 1
MX - Messico 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
Totale 2.559
Città #
Dublin 234
Singapore 211
Chandler 177
Parma 87
Dearborn 79
Boardman 69
New York 68
Ashburn 64
Izmir 64
Shanghai 60
Ann Arbor 55
Beijing 51
Nanjing 34
Princeton 34
Milan 33
Wilmington 31
Abidjan 18
Chicago 17
Shenyang 17
Bologna 15
Grafing 14
Helsinki 14
Munich 14
Nanchang 14
Hebei 13
Santa Clara 12
Bremen 11
Brussels 11
Guangzhou 11
Toronto 11
Houston 10
Jacksonville 10
Limena 9
Rio de Janeiro 9
Seattle 9
Montespertoli 8
Reggio Emilia 8
Taastrup 8
Changsha 7
Düsseldorf 7
Hangzhou 6
Jinan 6
Norwalk 6
Focsani 5
Jiaxing 5
Kunming 5
Los Angeles 5
Ottawa 5
Tianjin 5
Vienna 5
Zhengzhou 5
Ardea 4
Bordeaux 4
Des Moines 4
Falls Church 4
Hefei 4
Kocaeli 4
Lausanne 4
Modena 4
Piacenza 4
Rockville 4
Rome 4
Sant'ilario D'enza 4
Bangkok 3
Borås 3
Casalecchio di Reno 3
Cortemaggiore 3
Dallas 3
Fairfield 3
Istanbul 3
Naples 3
Nepi 3
San Mateo 3
Santa Margherita Ligure 3
Terni 3
Tokyo 3
Assago 2
Atlanta 2
Avrille 2
Dar es Salaam 2
Fabbrico 2
Frankfurt am Main 2
Fremont 2
Fuzhou 2
Haikou 2
Lanzhou 2
London 2
Mirandola 2
Phoenix 2
Prineville 2
Pune 2
San Francisco 2
San Giuliano Milanese 2
Santa Ana 2
Segrate 2
Sesto Fiorentino 2
São Paulo 2
Taipei 2
Taiyuan 2
Uithoorn 2
Totale 1.821
Nome #
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 146
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 96
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 86
Metabolic regulation of the HBV-specific T cell function 85
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 85
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 75
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 73
T cell regulation in HBV-related chronic liver disease 69
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 68
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 66
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 62
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 61
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 60
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 59
HBV immune-therapy: From molecular mechanisms to clinical applications 58
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 56
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 55
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 54
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 52
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 52
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 51
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 50
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells 48
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 48
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 46
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 46
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues 46
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 46
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 45
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 44
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 43
Comparative pathogenesis of HBV and HCV 40
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 38
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy 38
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection 38
Immunopathogenesis of hepatitis C virus infection 38
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 36
Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B 36
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 35
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B 34
Effector CD8(+) T cell-derived interleukin-10 enhances acute liver immunopathology 30
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor 29
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 26
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 26
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 26
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 25
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections 25
Therapeutic potential of co-signaling receptor modulation in hepatitis B 24
Hepatitis B virus specific immune response: From antigen recognition to liver damage 23
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 23
Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers 21
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire 20
The scientific basis of combination therapy for chronic hepatitis B functional cure 17
HBV antigens quantity: duration and effect on functional cure 15
T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection 12
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma 11
Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections 11
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma 9
Immunopathogenesis of hepatitis B 9
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 8
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 7
Totale 2.661
Categoria #
all - tutte 13.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 0 0 0 0 22 71 32 11 19 12 12 3
2020/2021142 2 6 1 1 16 15 20 13 29 15 9 15
2021/2022198 8 4 3 26 20 21 11 13 13 4 11 64
2022/2023771 82 66 42 49 58 78 15 40 258 6 40 37
2023/2024548 27 49 27 52 31 119 56 28 25 35 37 62
2024/2025490 63 91 102 127 107 0 0 0 0 0 0 0
Totale 2.661